万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生2>>遗传学
您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生3>>生物工程与应用微生物
您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生3>>医学(研究与实验)

HUMAN GENE THERAPY《人类基因治疗》 (官网投稿)

简介
  • 期刊简称HUM GENE THER
  • 参考译名《人类基因治疗》
  • 核心类别 SCIE(2024版), 目次收录(维普),外文期刊,
  • IF影响因子
  • 自引率4.40%
  • 主要研究方向医学-BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程与应用微生物;GENETICS & HEREDITY 遗传学;MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验

主要研究方向:

等待设置主要研究方向
医学-BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程与应用微生物;GENETICS & HEREDITY 遗传学;MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验

HUMAN GENE THERAPY《人类基因治疗》(半月刊). Human Gene Therapy (HGT) is the premier, multidisciplinary journal covering all aspects of gene therap...[显示全部]
征稿信息

万维提示:

1、投稿方式在线投稿。

2期刊网址:

https://home.liebertpub.com/publications/human-gene-therapy/19/

3投稿网址:https://mc.manuscriptcentral.com/hum

4、官网邮箱:HGT_EO@liebertpub.com(编辑部)

5、期刊刊期:半月刊,一年出版24期。

2021年8月26日星期

                                 

 

投稿须知【官网信息】

 

Human Gene Therapy

For Authors

Journal Information

Manuscript Submission Site: https://mc.manuscriptcentral.com/hum

Editorial Office Contact: HGT_EO@liebertpub.com

Support Contact: prosupport@liebertpub.com

Journal Model: Hybrid

Blinding: Single Blind

File formatting requirement stage: On revision. Format neutral on original submission.

Instant Online Option (immediate publication of accepted version): Yes

Submission Fee: None

Average time to initial decision: 21 days

About the Journal

Human Gene Therapy will consider manuscripts of very high quality that broadly fall under the scope of cell and gene therapy. Some general categories include studies evaluating novel approaches of cell and gene therapy in pre-clinical and clinical models; development of novel technologies; studies that help define mechanisms of action of cell and gene therapies; host interactions to vector and transplanted cells; and high-impact new methods and clinical trials.

Manuscripts on these topics may be submitted in the form of an original research article or a high impact protocol. Invited review articles and commentaries are usually solicited by the Editorial Board, but we also welcome unsolicited submissions of this type.

The Editors may quickly reject a manuscript soon after submission without external review if it falls outside the scope of the Journal or would not likely meet our high standards required for publication.

Manuscript Types and Guidelines

 

Original Research Articles

3,000-word limit

Unstructured abstract of no more than 300 words

Maximum of six (6) tables and/or figures

 

Review Articles

5,000-8,000-word limit

Unstructured abstract of no more than 300 words

Maximum of four (4) tables and/or figures

A maximum of 50 references is permitted

 

Research Articles- Methods

3,000-word limit

Unstructured abstract of no more than 300 words

Maximum of six (6) tables and/or figures

 

Research Articles – Clinical Development

3,000-word limit

Unstructured abstract of no more than 300 words

Maximum of six (6) tables and/or figures

 

Methods Protocols

3,000-word limit

Unstructured abstract of no more than 100 words

Maximum of six (6) tables and/or figures

 

Clinical Protocols

4,500-word limit

Unstructured abstract of no more than 300 words

Maximum of six (6) tables and/or figures

 

Pathways in Gene Therapy

2,000-word limit

No abstract

Maximum of two (2) tables and/or figures

 

Commentaries

1,200-word limit

No abstract

No tables or figures

 

News and Views

1,000-word limit

No abstract

No tables or figures

 

Letters to the Editor

500-word limit

May include one figure OR table

Reference citations are identical in style to those of full original articles, but should not exceed five (5).

Word limits do NOT pertain to the abstract, disclosure statements, author contribution statements, funding information, acknowledgments, tables, figure legends, or references.

Human Gene Therapy welcomes format-neutral manuscripts for first-time submissions. Newly submitted manuscripts will not be un-submitted for formatting issues. However, after the initial peer review process, revised submissions must follow correct journal formatting and file guidelines, as described below in the Instructions for Authors. Please note that there are certain compulsory elements (i.e.: IRB approvals, author disclosures, etc.) that must be included in all new submissions. Manuscripts submitted without this information will be un-submitted and the submitting author will be asked to add the required components.

……

更多详情:

https://home.liebertpub.com/publications/human-gene-therapy/19/for-authors


  • 万维QQ投稿交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP证合字09037080号

     纯自助论文投稿平台    E-mail:eshukan@163.com


投稿问答最小化  关闭